Sponsor Pipeline

The Second Affiliated Hospital of Shandong First Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06092242 The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line… Colorectal Cancer Not Yet Recruiting
NCT07109167 The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary… Biliary Tract Neoplasms Not Yet Recruiting
NCT07150377 A Phase II Single-Arm Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With… Hepatocellular Carcinoma (HCC) Not Yet Recruiting
NCT07160283 The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for… Biliary Tract Neoplasms Not Yet Recruiting
Disease Areas
Get alerts when The Second Affiliated Hospital of Shandong First Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free